Compound ID | 139
Class: Isothiazoloquinolone
| Spectrum of activity: | Gram-positive & Gram-negative |
| Details of activity: | Broad spectrum activity |
| Institute where first reported: | Achillion Pharmaceuticals, USA (outsourced to Ora, Inc.) |
| Year first mentioned: | 2008 |
| Highest developmental phase: | Preclinical |
| Development status: | Active |
| Chemical structure(s): | |||||||||||
|
|